Background Trabeculectomy remains the
Results One hundred and forty-two eyes of 100 patients were included in the study. When the criteria for success were an intraocular pressure (lOP) of less than 22 mmHg, 30% reduction from pre-operative levels and a decrease in visual acuity of less than 3 Snellen chart lines, then by life-table analysis success rates were 85%, 82% and 71% at the 1, 2 and 5 year post operative intervals respectively. Success rates were lower if an lOP of less than 16 mmHg was taken as one of the criteria (65%, 61% and 46% at the 1, 2 and 5 year intervals, respectively). Conclusions Trabeculectomy without antimetabolite use appears to be an effective way to lower the lOP of advanced glaucoma patients in Nigeria to less than 22 mmHg but not to less than 16 mmHg. The procedure, in experienced hands, is relatively safe with few major complications. 
Results
One hundred and thirty-four patients and 189 eyes were identified from the operating theatre records. One hundred patients and 142 eyes were included in the study. Thirty-two eyes of 24 patients who had uncomplicated trabeculectomy were excluded as follow up was less than 6 months. Thirteen eyes of 8 patients were excluded as they had had previous intraocular surgery. Also excluded were 1 eye each of patients with congenital glaucoma and acute angle closure glaucoma.
Average follow-up was 3 years. Patient details are shown in Table 1 . Age less than 50 years has been considered to Failure of surgery as defined occurred most frequently in the first 6 months after surgery but continued at a steady rate throughout the follow-up period.
Univariate analysis of survival curves (log-rank test)
showed that age less than 50 years did not appear to affect the trabeculectomy outcomes when the success criteria included an lOP less than 22 mmHg (p = 0.45).
When the success criteria included an lOP less than 16 mmHg then patients with age less than 50 years did significantly worse (p = 0.009).
Visual acuity decreased during the follow-up period.
Average loss (± standard error) of Snellen chart lines was 0.62 ± 0.15 by the end of follow-up. Pre-operatively 55.4% (79 eyes) of the eyes had a visual acuity of 6/12 or 
Month. AfterTrabeculectomy Table 2 . Progression of visual field loss to involve central vision was the commonest cause seen in 10 eyes (7%). Six of these 10 eyes had an lOP less than 16 mmHg. Progression of cataract was deemed to be the cause in 4 eyes (2.8%). Patients had refused cataract surgery in these cases.
Complications are shown in Table 3 . No endophthalmitis was observed in this cohort. Life- Glaucoma surgery was repeated in 16 eyes (11.3%). At the end of follow-up, the mean visual acuity of the entire group was reduced by approximately 1 Snellen chart line compared with pre-operative values (Fig. 3) .
This is in agreement with other reports, which show that reduction of visual acuity is a common event in the long term after trabeculectomy.13-1 5 It has been argued that even without an operation, glaucoma patients would experience a deterioration of best-corrected visual 't 1 6 ,17 I t' d f 1 acUl y.
n pa lents operate on or g aucoma the two common causes for decrease in vision are development or progression of cataract or progressive central field loss. We paid particular attention to visual acuity changes as most patients (85%) had advanced glaucomatous field loss, which encroached on fixation.
Lack of trained personnel to conduct the field tests and poor patient comprehension limited the value of visual field tests in this study. Therefore it was difficult to interpret the field tests for most patients except for those in whom field loss progressed to involve central vision.
In any case diagnosis of visual field progression remains difficult, particularly in eyes with advanced field loss, Higher follow-up rates were observed in this study compared with others 6 -10 from this region, probably due to the higher literacy and affluence of the patients. Also this study was conducted in the largest city in Nigeria where means of transportation are relatively better.
Comparisons between this study and studies on trabeculectomy outcomes in blacks in other parts of the world will be misleading for various reasons including differing criteria for success, technical skills of operating personnel, post-operative management and follow-up duration. One of the biggest problems in most studies is the lack of adequate follow-up 6 -l 0 ( Table 4) . If most patients are lost to follow-up immediately after surgery, it is impossible to know whether the majority of the defaulters are successes or failures, resulting in a biased study. We were unable to find in the literature a study originating from West Africa, or for that matter anywhere in Africa, which took this factor into account.
Survival curve or life-table analysis is a useful statistical tool to study outcomes in operated eyes when not all the patients have been followed for the entire study period.22
In this study, by considering the censored data (patients for whom no complete data were available because they were lost to follow-up or were still being followed), we could more accurately estimate survival times at 5FU in lowering lOP in the short term. However, they also found that mitomycin C use did not result in a significantly higher proportion of eyes achieving an lOP of less than 15 mmHg. Remarkably, they also reported that hypotony (lOP less than 5 mmHg) was seen in only 2 of 10 eyes following trabeculectomy with 5FU or mitomycin C. No case of hypotony-related maculopathy was seen and they concluded that this disorder is rare in black West Africans compared with whites?3
In conclusion, trabeculectomy without antimetabolite use appears to be an effective way to lower the lOP of advanced glaucoma patients in Nigeria to less than 278 22 mmHg but not to less than 16 mmHg. The procedure in experienced hands is relatively safe with few major complications. Cataract progression resulting in further diminution of visual acuity remains a concern and at least 29% of these patients will require cataract extraction within 5 years.
